Reuters logo
BRIEF-EU medicines agency recommends approval of Aveo's kidney cancer drug
2017年6月23日 / 中午12点25分 / 3 个月前

BRIEF-EU medicines agency recommends approval of Aveo's kidney cancer drug

June 23 (Reuters) - EU Medicines Agency:

* EU Medicines Agency recommendations for June 2017

* EU Medicines Agency recommends approval of Merck KGAA multiple sclerosis drug

* EU Medicines Agency recommends approval of Abbvie hepatitis C combination

* EU Medicines Agency recommends approval of Novartis Kisqali drug for breast cancer

* EU Medicines Agency recommends approval of Aveo drug for kidney cancer

* EU Medicines Agency recommends approval of biosimilar drug by Samsung Bioepis UK for Abbvie's rheumatoid arthritis drug Source text - (bit.ly/1j4Ivvu) Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below